EMEA (Europe, Middle East and Africa) API(Active Pharmaceutical Ingredient) Intermediate Market Report 2017

October 2017 | 102 pages | ID: E98C05E3233PEN
QYResearch

Abstracts

In this report, the EMEA API(Active Pharmaceutical Ingredient) Intermediate market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K MT), revenue (Million USD), market share and growth rate of API(Active Pharmaceutical Ingredient) Intermediate for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA API(Active Pharmaceutical Ingredient) Intermediate market competition by top manufacturers/players, with API(Active Pharmaceutical Ingredient) Intermediate sales volume (K MT), price (USD/MT), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Jigs Chemical
• Sanofi Winthrop Industrie S.A.
• Shandong Jiulong Fine Chemical Co., Ltd.
• Hipharma Limited
• AMPAC Fine Chemicals
• BASF
• Cambrex Corporation
• A R Life Sciences Pvt. Ltd.
• Dragon Hwa ChemPharm. Co., Ltd.
• Ami Life Sciences Pvt. Ltd.

On the basis of product, this report displays the sales volume (K MT), revenue (Million USD), product price (USD/MT), market share and growth rate of each type, primarily split into

• By Product
• Biotech Intermediates
• Chemical Intermediates
• By Type of Intermediate
• Patent Intermediates
• Non-patent Intermediates

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K MT), market share and growth rate of API(Active Pharmaceutical Ingredient) Intermediate for each application, including

• Oncology
• Diabetes
• Endocrinology
• Cardiovascular Disease
• CNS & Neurological Disorders

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) API(Active Pharmaceutical Ingredient) Intermediate Market Report 2017

1 API(ACTIVE PHARMACEUTICAL INGREDIENT) INTERMEDIATE OVERVIEW

1.1 Product Overview and Scope of API(Active Pharmaceutical Ingredient) Intermediate
1.2 Classification of API(Active Pharmaceutical Ingredient) Intermediate
  1.2.1 EMEA API(Active Pharmaceutical Ingredient) Intermediate Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA API(Active Pharmaceutical Ingredient) Intermediate Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Biotech Intermediates
  1.2.4 Chemical Intermediates
1.3 EMEA API(Active Pharmaceutical Ingredient) Intermediate Market by Application/End Users
  1.3.1 EMEA API(Active Pharmaceutical Ingredient) Intermediate Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Oncology
  1.3.3 Diabetes
  1.3.4 Endocrinology
  1.3.5 Cardiovascular Disease
  1.3.6 CNS & Neurological Disorders
1.4 EMEA API(Active Pharmaceutical Ingredient) Intermediate Market by Region
  1.4.1 EMEA API(Active Pharmaceutical Ingredient) Intermediate Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of API(Active Pharmaceutical Ingredient) Intermediate (2012-2022)
  1.5.1 EMEA API(Active Pharmaceutical Ingredient) Intermediate Sales and Growth Rate (2012-2022)
  1.5.2 EMEA API(Active Pharmaceutical Ingredient) Intermediate Revenue and Growth Rate (2012-2022)

2 EMEA API(ACTIVE PHARMACEUTICAL INGREDIENT) INTERMEDIATE COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA API(Active Pharmaceutical Ingredient) Intermediate Market Competition by Players/Manufacturers
  2.1.1 EMEA API(Active Pharmaceutical Ingredient) Intermediate Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA API(Active Pharmaceutical Ingredient) Intermediate Revenue and Share by Players (2012-2017)
  2.1.3 EMEA API(Active Pharmaceutical Ingredient) Intermediate Sale Price by Players (2012-2017)
2.2 EMEA API(Active Pharmaceutical Ingredient) Intermediate (Volume and Value) by Type/Product Category
  2.2.1 EMEA API(Active Pharmaceutical Ingredient) Intermediate Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA API(Active Pharmaceutical Ingredient) Intermediate Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA API(Active Pharmaceutical Ingredient) Intermediate Sale Price by Type (2012-2017)
2.3 EMEA API(Active Pharmaceutical Ingredient) Intermediate (Volume) by Application
2.4 EMEA API(Active Pharmaceutical Ingredient) Intermediate (Volume and Value) by Region
  2.4.1 EMEA API(Active Pharmaceutical Ingredient) Intermediate Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA API(Active Pharmaceutical Ingredient) Intermediate Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA API(Active Pharmaceutical Ingredient) Intermediate Sales Price by Region (2012-2017)

3 EUROPE API(ACTIVE PHARMACEUTICAL INGREDIENT) INTERMEDIATE (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe API(Active Pharmaceutical Ingredient) Intermediate Sales and Value (2012-2017)
  3.1.1 Europe API(Active Pharmaceutical Ingredient) Intermediate Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe API(Active Pharmaceutical Ingredient) Intermediate Revenue and Growth Rate (2012-2017)
3.2 Europe API(Active Pharmaceutical Ingredient) Intermediate Sales and Market Share by Type
3.3 Europe API(Active Pharmaceutical Ingredient) Intermediate Sales and Market Share by Application
3.4 Europe API(Active Pharmaceutical Ingredient) Intermediate Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe API(Active Pharmaceutical Ingredient) Intermediate Sales Volume by Countries (2012-2017)
  3.4.2 Europe API(Active Pharmaceutical Ingredient) Intermediate Revenue by Countries (2012-2017)
  3.4.3 Germany API(Active Pharmaceutical Ingredient) Intermediate Sales and Growth Rate (2012-2017)
  3.4.4 France API(Active Pharmaceutical Ingredient) Intermediate Sales and Growth Rate (2012-2017)
  3.4.5 UK API(Active Pharmaceutical Ingredient) Intermediate Sales and Growth Rate (2012-2017)
  3.4.6 Russia API(Active Pharmaceutical Ingredient) Intermediate Sales and Growth Rate (2012-2017)
  3.4.7 Italy API(Active Pharmaceutical Ingredient) Intermediate Sales and Growth Rate (2012-2017)
  3.4.8 Benelux API(Active Pharmaceutical Ingredient) Intermediate Sales and Growth Rate (2012-2017)

4 MIDDLE EAST API(ACTIVE PHARMACEUTICAL INGREDIENT) INTERMEDIATE (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East API(Active Pharmaceutical Ingredient) Intermediate Sales and Value (2012-2017)
  4.1.1 Middle East API(Active Pharmaceutical Ingredient) Intermediate Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East API(Active Pharmaceutical Ingredient) Intermediate Revenue and Growth Rate (2012-2017)
4.2 Middle East API(Active Pharmaceutical Ingredient) Intermediate Sales and Market Share by Type
4.3 Middle East API(Active Pharmaceutical Ingredient) Intermediate Sales and Market Share by Application
4.4 Middle East API(Active Pharmaceutical Ingredient) Intermediate Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East API(Active Pharmaceutical Ingredient) Intermediate Sales Volume by Countries (2012-2017)
  4.4.2 Middle East API(Active Pharmaceutical Ingredient) Intermediate Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia API(Active Pharmaceutical Ingredient) Intermediate Sales and Growth Rate (2012-2017)
  4.4.4 Israel API(Active Pharmaceutical Ingredient) Intermediate Sales and Growth Rate (2012-2017)
  4.4.5 UAE API(Active Pharmaceutical Ingredient) Intermediate Sales and Growth Rate (2012-2017)
  4.4.6 Iran API(Active Pharmaceutical Ingredient) Intermediate Sales and Growth Rate (2012-2017)

5 AFRICA API(ACTIVE PHARMACEUTICAL INGREDIENT) INTERMEDIATE (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa API(Active Pharmaceutical Ingredient) Intermediate Sales and Value (2012-2017)
  5.1.1 Africa API(Active Pharmaceutical Ingredient) Intermediate Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa API(Active Pharmaceutical Ingredient) Intermediate Revenue and Growth Rate (2012-2017)
5.2 Africa API(Active Pharmaceutical Ingredient) Intermediate Sales and Market Share by Type
5.3 Africa API(Active Pharmaceutical Ingredient) Intermediate Sales and Market Share by Application
5.4 Africa API(Active Pharmaceutical Ingredient) Intermediate Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa API(Active Pharmaceutical Ingredient) Intermediate Sales Volume by Countries (2012-2017)
  5.4.2 Africa API(Active Pharmaceutical Ingredient) Intermediate Revenue by Countries (2012-2017)
  5.4.3 South Africa API(Active Pharmaceutical Ingredient) Intermediate Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria API(Active Pharmaceutical Ingredient) Intermediate Sales and Growth Rate (2012-2017)
  5.4.5 Egypt API(Active Pharmaceutical Ingredient) Intermediate Sales and Growth Rate (2012-2017)
  5.4.6 Algeria API(Active Pharmaceutical Ingredient) Intermediate Sales and Growth Rate (2012-2017)

6 EMEA API(ACTIVE PHARMACEUTICAL INGREDIENT) INTERMEDIATE MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Jigs Chemical
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 API(Active Pharmaceutical Ingredient) Intermediate Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Jigs Chemical API(Active Pharmaceutical Ingredient) Intermediate Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Sanofi Winthrop Industrie S.A.
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 API(Active Pharmaceutical Ingredient) Intermediate Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Sanofi Winthrop Industrie S.A. API(Active Pharmaceutical Ingredient) Intermediate Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Shandong Jiulong Fine Chemical Co., Ltd.
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 API(Active Pharmaceutical Ingredient) Intermediate Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Shandong Jiulong Fine Chemical Co., Ltd. API(Active Pharmaceutical Ingredient) Intermediate Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Hipharma Limited
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 API(Active Pharmaceutical Ingredient) Intermediate Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Hipharma Limited API(Active Pharmaceutical Ingredient) Intermediate Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 AMPAC Fine Chemicals
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 API(Active Pharmaceutical Ingredient) Intermediate Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 AMPAC Fine Chemicals API(Active Pharmaceutical Ingredient) Intermediate Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 BASF
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 API(Active Pharmaceutical Ingredient) Intermediate Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 BASF API(Active Pharmaceutical Ingredient) Intermediate Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Cambrex Corporation
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 API(Active Pharmaceutical Ingredient) Intermediate Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Cambrex Corporation API(Active Pharmaceutical Ingredient) Intermediate Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 A R Life Sciences Pvt. Ltd.
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 API(Active Pharmaceutical Ingredient) Intermediate Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 A R Life Sciences Pvt. Ltd. API(Active Pharmaceutical Ingredient) Intermediate Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Dragon Hwa ChemPharm. Co., Ltd.
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 API(Active Pharmaceutical Ingredient) Intermediate Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Dragon Hwa ChemPharm. Co., Ltd. API(Active Pharmaceutical Ingredient) Intermediate Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Ami Life Sciences Pvt. Ltd.
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 API(Active Pharmaceutical Ingredient) Intermediate Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Ami Life Sciences Pvt. Ltd. API(Active Pharmaceutical Ingredient) Intermediate Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview

7 API(ACTIVE PHARMACEUTICAL INGREDIENT) INTERMEDIATE MANUFACTURING COST ANALYSIS

7.1 API(Active Pharmaceutical Ingredient) Intermediate Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of API(Active Pharmaceutical Ingredient) Intermediate

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 API(Active Pharmaceutical Ingredient) Intermediate Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of API(Active Pharmaceutical Ingredient) Intermediate Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA API(ACTIVE PHARMACEUTICAL INGREDIENT) INTERMEDIATE MARKET FORECAST (2017-2022)

11.1 EMEA API(Active Pharmaceutical Ingredient) Intermediate Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA API(Active Pharmaceutical Ingredient) Intermediate Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA API(Active Pharmaceutical Ingredient) Intermediate Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA API(Active Pharmaceutical Ingredient) Intermediate Price and Trend Forecast (2017-2022)
11.2 EMEA API(Active Pharmaceutical Ingredient) Intermediate Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe API(Active Pharmaceutical Ingredient) Intermediate Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt API(Active Pharmaceutical Ingredient) Intermediate Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa API(Active Pharmaceutical Ingredient) Intermediate Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA API(Active Pharmaceutical Ingredient) Intermediate Sales Forecast by Type (2017-2022)
11.7 EMEA API(Active Pharmaceutical Ingredient) Intermediate Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of API(Active Pharmaceutical Ingredient) Intermediate
Figure EMEA API(Active Pharmaceutical Ingredient) Intermediate Sales Volume (K MT) by Type (2012-2022)
Figure EMEA API(Active Pharmaceutical Ingredient) Intermediate Sales Volume Market Share by Type (Product Category) in 2016
Figure Biotech Intermediates Product Picture
Figure Chemical Intermediates Product Picture
Figure EMEA API(Active Pharmaceutical Ingredient) Intermediate Sales Volume (K MT) by Application (2012-2022)
Figure EMEA Sales Market Share of API(Active Pharmaceutical Ingredient) Intermediate by Application in 2016
Figure Oncology Examples
Table Key Downstream Customer in Oncology
Figure Diabetes Examples
Table Key Downstream Customer in Diabetes
Figure Endocrinology Examples
Table Key Downstream Customer in Endocrinology
Figure Cardiovascular Disease Examples
Table Key Downstream Customer in Cardiovascular Disease
Figure CNS & Neurological Disorders Examples
Table Key Downstream Customer in CNS & Neurological Disorders
Figure EMEA API(Active Pharmaceutical Ingredient) Intermediate Market Size (Million USD) by Region (2012-2022)
Figure Europe API(Active Pharmaceutical Ingredient) Intermediate Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe API(Active Pharmaceutical Ingredient) Intermediate Revenue (Million USD) Status and Forecast by Countries
Figure Middle East API(Active Pharmaceutical Ingredient) Intermediate Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East API(Active Pharmaceutical Ingredient) Intermediate Revenue (Million USD) Status and Forecast by Countries
Figure Africa API(Active Pharmaceutical Ingredient) Intermediate Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa API(Active Pharmaceutical Ingredient) Intermediate Revenue (Million USD) Status and Forecast by Countries
Figure EMEA API(Active Pharmaceutical Ingredient) Intermediate Sales Volume and Growth Rate (2012-2022)
Figure EMEA API(Active Pharmaceutical Ingredient) Intermediate Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA API(Active Pharmaceutical Ingredient) Intermediate Market Major Players Product Sales Volume (K MT) (2012-2017)
Table EMEA API(Active Pharmaceutical Ingredient) Intermediate Sales Volume (K MT) of Major Players (2012-2017)
Table EMEA API(Active Pharmaceutical Ingredient) Intermediate Sales Share by Players (2012-2017)
Figure 2016 API(Active Pharmaceutical Ingredient) Intermediate Sales Share by Players
Figure 2017 API(Active Pharmaceutical Ingredient) Intermediate Sales Share by Players
Figure EMEA API(Active Pharmaceutical Ingredient) Intermediate Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA API(Active Pharmaceutical Ingredient) Intermediate Revenue (Million USD) by Players (2012-2017)
Table EMEA API(Active Pharmaceutical Ingredient) Intermediate Revenue Share by Players (2012-2017)
Table 2016 EMEA API(Active Pharmaceutical Ingredient) Intermediate Revenue Share by Players
Table 2017 EMEA API(Active Pharmaceutical Ingredient) Intermediate Revenue Share by Players
Table EMEA API(Active Pharmaceutical Ingredient) Intermediate Sale Price (USD/MT) by Players (2012-2017)
Table EMEA API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) and Market Share by Type (2012-2017)
Table EMEA API(Active Pharmaceutical Ingredient) Intermediate Sales Share by Type (2012-2017)
Figure Sales Market Share of API(Active Pharmaceutical Ingredient) Intermediate by Type (2012-2017)
Figure EMEA API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Type (2012-2017)
Table EMEA API(Active Pharmaceutical Ingredient) Intermediate Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA API(Active Pharmaceutical Ingredient) Intermediate Revenue Share by Type (2012-2017)
Figure Revenue Market Share of API(Active Pharmaceutical Ingredient) Intermediate by Type in 2016
Table EMEA API(Active Pharmaceutical Ingredient) Intermediate Sale Price (USD/MT) by Type (2012-2017)
Table EMEA API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) and Market Share by Application (2012-2017)
Table EMEA API(Active Pharmaceutical Ingredient) Intermediate Sales Share by Application (2012-2017)
Figure Sales Market Share of API(Active Pharmaceutical Ingredient) Intermediate by Application (2012-2017)
Figure EMEA API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Application in 2016
Table EMEA API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) and Market Share by Region (2012-2017)
Table EMEA API(Active Pharmaceutical Ingredient) Intermediate Sales Share by Region (2012-2017)
Figure Sales Market Share of API(Active Pharmaceutical Ingredient) Intermediate by Region (2012-2017)
Figure EMEA API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share in 2016
Table EMEA API(Active Pharmaceutical Ingredient) Intermediate Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA API(Active Pharmaceutical Ingredient) Intermediate Revenue Share by Region (2012-2017)
Figure Revenue Market Share of API(Active Pharmaceutical Ingredient) Intermediate by Region (2012-2017)
Figure EMEA API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share Regions in 2016
Table EMEA API(Active Pharmaceutical Ingredient) Intermediate Sales Price (USD/MT) by Region (2012-2017)
Figure Europe API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) and Growth Rate (2012-2017)
Figure Europe API(Active Pharmaceutical Ingredient) Intermediate Revenue and Growth Rate (2012-2017)
Table Europe API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) by Type (2012-2017)
Table Europe API(Active Pharmaceutical Ingredient) Intermediate Market Share by Type (2012-2017)
Figure Europe API(Active Pharmaceutical Ingredient) Intermediate Market Share by Type in 2016
Table Europe API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) by Application (2012-2017)
Table Europe API(Active Pharmaceutical Ingredient) Intermediate Market Share by Application (2012-2017)
Figure Europe API(Active Pharmaceutical Ingredient) Intermediate Market Share by Application in 2016
Table Europe API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) by Countries (2012-2017)
Table Europe API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Countries (2012-2017)
Figure Europe API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Countries (2012-2017)
Figure Europe API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Countries in 2016
Table Europe API(Active Pharmaceutical Ingredient) Intermediate Revenue (Million USD) by Countries (2012-2017)
Table Europe API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share by Countries (2012-2017)
Figure Europe API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share by Countries (2012-2017)
Figure Europe API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share by Countries in 2016
Figure Germany API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) and Growth Rate (2012-2017)
Figure France API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) and Growth Rate (2012-2017)
Figure UK API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) and Growth Rate (2012-2017)
Figure Russia API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) and Growth Rate (2012-2017)
Figure Italy API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) and Growth Rate (2012-2017)
Figure Benelux API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) and Growth Rate (2012-2017)
Figure Middle East API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) and Growth Rate (2012-2017)
Figure Middle East API(Active Pharmaceutical Ingredient) Intermediate Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) by Type (2012-2017)
Table Middle East API(Active Pharmaceutical Ingredient) Intermediate Market Share by Type (2012-2017)
Figure Middle East API(Active Pharmaceutical Ingredient) Intermediate Market Share by Type (2012-2017)
Table Middle East API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) by Applications (2012-2017)
Table Middle East API(Active Pharmaceutical Ingredient) Intermediate Market Share by Applications (2012-2017)
Figure Middle East API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Application in 2016
Table Middle East API(Active Pharmaceutical Ingredient) Intermediate Sales Volume (K MT) by Countries (2012-2017)
Table Middle East API(Active Pharmaceutical Ingredient) Intermediate Sales Volume Market Share by Countries (2012-2017)
Figure Middle East API(Active Pharmaceutical Ingredient) Intermediate Sales Volume Market Share by Countries in 2016
Table Middle East API(Active Pharmaceutical Ingredient) Intermediate Revenue (Million USD) by Countries (2012-2017)
Table Middle East API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share by Countries (2012-2017)
Figure Middle East API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share by Countries (2012-2017)
Figure Middle East API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share by Countries in 2016
Figure Saudi Arabia API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) and Growth Rate (2012-2017)
Figure Israel API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) and Growth Rate (2012-2017)
Figure UAE API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) and Growth Rate (2012-2017)
Figure Iran API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) and Growth Rate (2012-2017)
Figure Africa API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) and Growth Rate (2012-2017)
Figure Africa API(Active Pharmaceutical Ingredient) Intermediate Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) by Type (2012-2017)
Table Africa API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Type (2012-2017)
Figure Africa API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Type (2012-2017)
Figure Africa API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Type in 2016
Table Africa API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) by Application (2012-2017)
Table Africa API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Application (2012-2017)
Figure Africa API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Application (2012-2017)
Table Africa API(Active Pharmaceutical Ingredient) Intermediate Sales Volume (K MT) by Countries (2012-2017)
Table Africa API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Countries (2012-2017)
Figure Africa API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Countries (2012-2017)
Figure Africa API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Countries in 2016
Table Africa API(Active Pharmaceutical Ingredient) Intermediate Revenue (Million USD) by Countries (2012-2017)
Table Africa API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share by Countries (2012-2017)
Figure Africa API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share by Countries (2012-2017)
Figure Africa API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share by Countries in 2016
Figure South Africa API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) and Growth Rate (2012-2017)
Figure Nigeria API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) and Growth Rate (2012-2017)
Figure Egypt API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) and Growth Rate (2012-2017)
Figure Algeria API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) and Growth Rate (2012-2017)
Table Jigs Chemical API(Active Pharmaceutical Ingredient) Intermediate Basic Information List
Table Jigs Chemical API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Jigs Chemical API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) and Growth Rate (2012-2017)
Figure Jigs Chemical API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share in EMEA (2012-2017)
Figure Jigs Chemical API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share in EMEA (2012-2017)
Table Sanofi Winthrop Industrie S.A. API(Active Pharmaceutical Ingredient) Intermediate Basic Information List
Table Sanofi Winthrop Industrie S.A. API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Sanofi Winthrop Industrie S.A. API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) and Growth Rate (2012-2017)
Figure Sanofi Winthrop Industrie S.A. API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share in EMEA (2012-2017)
Figure Sanofi Winthrop Industrie S.A. API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share in EMEA (2012-2017)
Table Shandong Jiulong Fine Chemical Co., Ltd. API(Active Pharmaceutical Ingredient) Intermediate Basic Information List
Table Shandong Jiulong Fine Chemical Co., Ltd. API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Shandong Jiulong Fine Chemical Co., Ltd. API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) and Growth Rate (2012-2017)
Figure Shandong Jiulong Fine Chemical Co., Ltd. API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share in EMEA (2012-2017)
Figure Shandong Jiulong Fine Chemical Co., Ltd. API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share in EMEA (2012-2017)
Table Hipharma Limited API(Active Pharmaceutical Ingredient) Intermediate Basic Information List
Table Hipharma Limited API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Hipharma Limited API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) and Growth Rate (2012-2017)
Figure Hipharma Limited API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share in EMEA (2012-2017)
Figure Hipharma Limited API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share in EMEA (2012-2017)
Table AMPAC Fine Chemicals API(Active Pharmaceutical Ingredient) Intermediate Basic Information List
Table AMPAC Fine Chemicals API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure AMPAC Fine Chemicals API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) and Growth Rate (2012-2017)
Figure AMPAC Fine Chemicals API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share in EMEA (2012-2017)
Figure AMPAC Fine Chemicals API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share in EMEA (2012-2017)
Table BASF API(Active Pharmaceutical Ingredient) Intermediate Basic Information List
Table BASF API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure BASF API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) and Growth Rate (2012-2017)
Figure BASF API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share in EMEA (2012-2017)
Figure BASF API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share in EMEA (2012-2017)
Table Cambrex Corporation API(Active Pharmaceutical Ingredient) Intermediate Basic Information List
Table Cambrex Corporation API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Cambrex Corporation API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) and Growth Rate (2012-2017)
Figure Cambrex Corporation API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share in EMEA (2012-2017)
Figure Cambrex Corporation API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share in EMEA (2012-2017)
Table A R Life Sciences Pvt. Ltd. API(Active Pharmaceutical Ingredient) Intermediate Basic Information List
Table A R Life Sciences Pvt. Ltd. API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure A R Life Sciences Pvt. Ltd. API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) and Growth Rate (2012-2017)
Figure A R Life Sciences Pvt. Ltd. API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share in EMEA (2012-2017)
Figure A R Life Sciences Pvt. Ltd. API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share in EMEA (2012-2017)
Table Dragon Hwa ChemPharm. Co., Ltd. API(Active Pharmaceutical Ingredient) Intermediate Basic Information List
Table Dragon Hwa ChemPharm. Co., Ltd. API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Dragon Hwa ChemPharm. Co., Ltd. API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) and Growth Rate (2012-2017)
Figure Dragon Hwa ChemPharm. Co., Ltd. API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share in EMEA (2012-2017)
Figure Dragon Hwa ChemPharm. Co., Ltd. API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share in EMEA (2012-2017)
Table Ami Life Sciences Pvt. Ltd. API(Active Pharmaceutical Ingredient) Intermediate Basic Information List
Table Ami Life Sciences Pvt. Ltd. API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Ami Life Sciences Pvt. Ltd. API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) and Growth Rate (2012-2017)
Figure Ami Life Sciences Pvt. Ltd. API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share in EMEA (2012-2017)
Figure Ami Life Sciences Pvt. Ltd. API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share in EMEA (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of API(Active Pharmaceutical Ingredient) Intermediate
Figure Manufacturing Process Analysis of API(Active Pharmaceutical Ingredient) Intermediate
Figure API(Active Pharmaceutical Ingredient) Intermediate Industrial Chain Analysis
Table Raw Materials Sources of API(Active Pharmaceutical Ingredient) Intermediate Major Manufacturers in 2016
Table Major Buyers of API(Active Pharmaceutical Ingredient) Intermediate
Table Distributors/Traders List
Figure EMEA API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) and Growth Rate Forecast (2017-2022)
Figure EMEA API(Active Pharmaceutical Ingredient) Intermediate Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA API(Active Pharmaceutical Ingredient) Intermediate Price (USD/MT) and Trend Forecast (2017-2022)
Table EMEA API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) Forecast by Region (2017-2022)
Figure EMEA API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share Forecast by Region (2017-2022)
Table EMEA API(Active Pharmaceutical Ingredient) Intermediate Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share Forecast by Region (2017-2022)
Table Europe API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) Forecast by Countries (2017-2022)
Figure Europe API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share Forecast by Countries (2017-2022)
Table Europe API(Active Pharmaceutical Ingredient) Intermediate Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) Forecast by Countries (2017-2022)
Figure Middle East API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share Forecast by Countries (2017-2022)
Table Middle East API(Active Pharmaceutical Ingredient) Intermediate Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share Forecast by Countries (2017-2022)
Table Africa API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) Forecast by Countries (2017-2022)
Figure Africa API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share Forecast by Countries (2017-2022)
Table Africa API(Active Pharmaceutical Ingredient) Intermediate Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) Forecast by Type (2017-2022)
Figure EMEA API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share Forecast by Type (2017-2022)
Table EMEA API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) Forecast by Application (2017-2022)
Figure EMEA API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources